Investing
Top Analyst Upgrades (AGN, CHU, ENDP, FLR, GD, LMT, MDZ, NETL, NUVA, SGR)
Published:
These are the top pre-market analyst upgrades and positive research calls we have seen from Wall Street this Tuesday morning:
Allergan (AGN) Raised to Overweight at Thomas Weisel.
China Unicom (CHU) Raised to Buy at UBS.
Endo Pharmaceuticals (ENDP) Started as Overweight at Thomas Weisel.
Fluor (FLR) Started as Outperform at Baird.
General Dynamics (GD) Started as Outperform at Morgan Keegan.
Lockheed Martin (LMT) Started as Outperform at Morgan Keegan.
MDS Inc. (MDZ) Raised to Buy at Jefferies.
NetLogic (NETL) Raised to Buy at Piper Jaffray.
Nuvasive (NUVA) Raised to Buy at Needham.
Shaw Group (SGR) Started as Outperform at Baird.
JON C. OGG
Retirement can be daunting, but it doesn’t need to be.
Imagine having an expert in your corner to help you with your financial goals. Someone to help you determine if you’re ahead, behind, or right on track. With SmartAsset, that’s not just a dream—it’s reality. This free tool connects you with pre-screened financial advisors who work in your best interests. It’s quick, it’s easy, so take the leap today and start planning smarter!
Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.